-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
-
Summary
-
Rein Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2023 to Q4 2024.
- Rein Therapeutics, Inc. Goodwill for the quarter ending December 31, 2024 was $6.33M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)